There are some big things cooking; Lily, FDA stages, LFRP, and maybe a buyout.
It was a long 8 year struggle holding on this stock.
A buyout at $20 is dream. Lily news brings this $12, and any other good brings us $10.
Downside is mismanagement, lets face it, they have a garbage track record.